Disease | antiphospholipid syndrome |
Comorbidity | C0040034|thrombocytopenia |
Sentences | 4 |
PubMedID- 22039845 | This article will review the evidence-based management of heparin induced thrombocytopenia with thrombosis, anti-phospholipid antibody syndrome and catastrophic anti-phospholipid antibody syndrome, thrombohemorrhagic manifestations of philadelphia chromosome-negative chronic myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia and primary myelofibrosis, as well as paroxysmal nocturnal hemoglobinuria. |
PubMedID- 20345710 | False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal. |
PubMedID- 25740703 | The significance and management of thrombocytopenia in antiphospholipid syndrome. |
PubMedID- 24106491 | They develop anti-rna and anti-phospholipid autoantibodies, severe inflammatory nephritis and anti-phospholipid syndrome with thrombocytopenia, myocardial infarcts, and cardiomyopathy (41, 42). |
Page: 1